T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection
- 1 November 2000
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 30 (11) , 3067-3078
- https://doi.org/10.1002/1521-4141(200011)30:11<3067::aid-immu3067>3.0.co;2-l
Abstract
T cells specific for a single viral epitope, but using different T cell receptors, should have flexibility in their epitope recognition to protect the infected host against the emergence of viral escape mutants. Therefore, polyclonality of the hepatitis B virus (HBV)‐specific cytotoxic T lymphocyte response has been hypothesized to be a major determinant in the control of infection. We analyzed the Vβ chain composition of the core 18‐27‐specific CD8 cells in acute and persistently HBV‐infected patients using HLA‐A2 tetrameric complexes and a panel of Vβ antibodies. Different T cell receptors were utilized by core 18‐27‐specific CD8 cells both in patients with acute and chronic infection. The functional ability of these epitope‐specific T cells to respond to potential viral mutations was then tested. The polyclonal HBV‐specific CD8 response present in patients with acute hepatitis displayed a limited efficiency to recognize mutations introduced within the epitope. The ability of core 18‐27‐specific CD8 to tolerate epitope mutations was found only during persistent HBV infection. The data suggest that although a clonally heterogeneous CD8 response can be largely inhibited by the occurrence of single epitope mutations in primary HBV infection, preferential selection of T cells able to counteract the emergence of viral mutations can occur during persistent infection.Keywords
This publication has 27 references indexed in Scilit:
- Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptorHepatology, 1997
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.The Journal of Experimental Medicine, 1996
- Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.The Journal of Experimental Medicine, 1994
- Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cellsNature, 1994
- Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition.The Journal of Experimental Medicine, 1993
- In a small multideterminant peptide, each determinant is recognized by a different V beta gene segment.The Journal of Experimental Medicine, 1992
- Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.The Journal of Experimental Medicine, 1991
- Viral escape by selection of cytotoxic T cell-resistant virus variants in vivoNature, 1990
- T-cell antigen receptor genes and T-cell recognitionNature, 1988